ReviewCancers2026

Oral Estrogen Receptor Degraders Compared to Standard Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Systematic Review and Meta-Analysis.

Hadar Goldvaser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.